GLP-1 drugs achieve some of these effects by directly affecting the brain’s cravings for food, and that might also extend to cravings for alcohol, said senior researcher Dr. Carel le Roux, chair of experimental pathology at University College Dublin in Ireland.

David Kessler has lost more than 60 pounds on weight-loss drugs and believes they can change the trajectory of chronic disease in the United States.

First-generation GLP-1 weight-loss drugs can help reduce the risk of obesity-related cancers, new research shows. Liraglutide, exenatide, and dulaglutide were 41% more effective at preventing obesity-related cancers.

A weekly dose of semaglutide, a drug used to manage diabetes and weight loss, was effective in 63% of patients at treating a serious form of fatty liver disease, a new study has found.

GLP-1 medications like semaglutide and tirzepatide have exploded in popularity, with millions of Americans turning to them for weight loss. But are they the magic bullet for sustainable results? The

Fact checked by Nick Blackmer Tirzepatide and semaglutide, the ingredients in popular weight loss drugs, can both cause side effects, such as nausea, vomiting, and diarrhea.One is not safer than the other—tolerance to the medications largely depends on the patient.

New research has found that GLP-1 drugs can substantially reduce the risk of obesity-related cancers — and they’re more effective than getting weight loss surgery.

Reducing exposure to medicines is always a good thing if similar clinical outcomes can be achieved, and the study suggests it may be possible to improve the efficacy of semaglutide and other GLP-1 acting drugs, which can have side effects including nausea, diarrhoea, vomiting, constipation, stomach pain, headache, and tiredness, amongst others.

Weight-loss injections, or GLP-1 receptor agonists, could nearly halve the risk of obesity-related cancers, a new study finds amid rising global obesity rates.

According to a recent Kaiser Family Foundation poll, roughly 6% of U.S. adults are currently taking GLP-1 for weight loss, and the effects are impressive. A 2022 study found that people who received weekly semaglutide injections lost an average of about 15 pounds after three months.

Former FDA Commissioner David Kessler shared his experience with GLP-1 weight loss drugs on "CBS Mornings Plus."